Reynolds, Kerry Lynn http://orcid.org/0000-0002-7793-654X
Bedard, Philippe L.
Lee, Se-Hoon
Lin, Chia-Chi
Tabernero, Josep
Alsina, Maria
Cohen, Ezra
Baselga, José
Blumenschein, George Jr
Graham, Donna M.
Garrido-Laguna, Ignacio
Juric, Dejan
Sharma, Sunil
Salgia, Ravi
Seroutou, Abdelkader
Tian, Xianbin
Fernandez, Rose
Morozov, Alex
Sheng, Qing
Ramkumar, Thiruvamoor
Zubel, Angela
Bang, Yung-Jue
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 13 September 2016
Accepted: 4 September 2017
First Online: 12 September 2017
Ethics approval and consent to participate
: This study was performed in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice. All patients provided written informed consent before any study procedures. This study was approved by the ethics committee of Massachusetts General Hospital (Office for Human Research Studies), Princess Margaret Cancer Centre (University Health Network Research Ethics Board), Seoul National University Hospital Clinical Research Institute, National Taiwan University Hospital Research Ethics Committee, Vall d’Hebron University Hospital (CEIC Hospital Vall Hebron), University of Utah IRB, University of Texas MD Anderson Cancer Center IRB, and University of Chicago IRB.
: Not applicable.
: Kerry Lynn Reynolds, Maria Alsina, José Baselga, Ezra Cohen, Ignacio Garrido-Laguna, Chia-Chi Lin, Donna M. Graham, Se-Hoon Lee, and Ravi Salgia have no conflicts of interest to declare. Josep Tabernero has received minor funding as a compensated consultant/advisory board member for Amgen, Boehringer Ingelheim, Celgene, Chugai, Imclone, Lilly, Merck, Merck Serono, Millennium, Novartis Pharmaceuticals Corporation, Roche, Sanofi, Symphogen and Taiho. Yung-Jue Bang has received minor funding as a consultant/advisory board member for Novartis Pharmaceuticals Corporation. Dejan Juric has received minor funding as a consultant/advisory board member for Novartis Pharmaceuticals Corporation, Eisai, and EMD Serono. Sunil Sharma has received a commercial research grant from Novartis Pharmaceuticals Corporation. Philippe Bedard has received institutional funding from Novartis Pharmaceuticals Corporation. George Blumenschein has acted as a compensated consultant and/or advisory board member for BMS, Bayer, Clovis, Merck, AstraZeneca, Ariad, Celgene, and AbbVie, and has received commercial research grants from BMS, Bayer, Celgene, Novartis, Xcovery, Adaptimmune, Immatics, and AstraZeneca. Abdelkader Seroutou, Xianbin Tian, Rose Fernandez, Alex Morozov*, Qing Sheng, Thiruvamoor Ramkumar, and Angela Zubel are employees of Novartis Pharmaceuticals Corporation.*Now an employee of Pfizer Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.